Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

NM21-1480

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

CStone Pharma, Numab

Drug class:

PD-L1 inhibitor, CD137 agonist

Related drugs:

atezolizumab (236)

durvalumab (200)

benmelstobart (12)

sugemalimab (7)

envafolimab (6)

imsapepimut and etimupepimut, adjuvanted (4)

socazolimab (2)

atezolizumab and hyaluronidase-tqjs (1)

cosibelimab-ipdl (1)

adebrelimab (0)

CF33-hNIS-antiPDL1 (0)

PD-L1.t-haNK (0)

PF-07257876 (0)

Undisclosed anti-PD-L1 antibody (0)

ALG.APV-527 (1)

PF-08046049 (1)

PF-05082566 (1)

›